EUVIMEDEUVIMED entdecken
Crossref

Spatiotemporally Engineered POSS Nanoplatform for Multi‐Organelle‐Targeted Synergistic Photothermal‐Chemo‐Immunotherapy

Xiaoying Ma, Yang Li, Sina Chen, Peipei Xu, Shanyi Guang, Hongyao Xu, Shouchun Yin iD

Advanced Healthcare Materials · 2026-04 · 15 (13)

DOI: 10.1002/adhm.202505008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 15.01.2026. Verfasst von Xiaoying Ma und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Advanced Fiber Materials, College of Materials Science and Engineering, Donghua University, Shanghai, China. Hauptthemen laut MEDLINE: Immunotherapy, Organosilicon Compounds, Nanoparticles. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: Natural Science Foundation of Zhejiang Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumor heterogeneity and immunosuppression limit the efficacy of conventional immunotherapy. Here, we introduce a spatiotemporally engineered nanoplatform ( CAP/CyOH@NPs ) that achieves multi‐organelle targeting in tumor cells through POSS‐based nanoconfinement. The rigid POSS cage co‐encapsulates a photothermal agent (CyOH) and chemotherapeutic prodrug (capecitabine), enabling stable, simultaneous localization to lysosomes, mitochondria, and the endoplasmic reticulum‐independent of pH or membrane potential. This subcellular precision enhances photothermal conversion (53.4%) and amplifies immunogenic cell death via coordinated organelle stress. When combined with PD‐L1 blockade, the platform remodels the tumor immune microenvironment and suppresses both primary and distant tumors in a 4T1 breast cancer model. This work establishes a new paradigm for engineering nanomedicines with organelle‐level specificity, offering a versatile strategy to overcome resistance in precision oncology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunotherapyOrganosilicon CompoundsNanoparticlesAnimalsCell Line, TumorFemaleTumor MicroenvironmentMiceHumansProdrugsMice, Inbred BALB CLysosomes

Stichwörter der Autor:innen

immunogenic cell deathmulti‐organelle targetingnanoplatformpolyhedral oligomeric silsesquioxane (POSS)tumor microenvironment remodeling

Substanzen

Organosilicon CompoundsProdrugs

Autor:innen und Institutionen

  • State Key Laboratory of Advanced Fiber Materials, College of Materials Science and Engineering, Donghua University, Shanghai, China.
  • College of Materials, Chemistry and Chemical Engineering, Key Laboratory of Organosilicon Chemistry and Materials Technology of Ministry of Education, Hangzhou Normal University, Hangzhou, China.
  • College of Chemistry and Chemical Engineering, Donghua University, Shanghai, China.
  • College of Materials and Chemical Engineering, Fuyang University of Technology, Fuyang, China.

ORCID-Profile: Shouchun Yin

Förderung

  • Natural Science Foundation of Zhejiang Province
  • National Natural Science Foundation of China

Zitieren

APA

Ma, X., Li, Y., Chen, S., Xu, P., Guang, S., Xu, H., & Yin, S. (2026). Spatiotemporally Engineered POSS Nanoplatform for Multi‐Organelle‐Targeted Synergistic Photothermal‐Chemo‐Immunotherapy. Advanced Healthcare Materials, 15(13). https://doi.org/10.1002/adhm.202505008

Vancouver

Ma X, Li Y, Chen S, Xu P, Guang S, Xu H, et al. Spatiotemporally Engineered POSS Nanoplatform for Multi‐Organelle‐Targeted Synergistic Photothermal‐Chemo‐Immunotherapy. Advanced Healthcare Materials. 2026;15(13). doi:10.1002/adhm.202505008

BibTeX
@article{Ma2026,
  author = {Ma, Xiaoying and Li, Yang and Chen, Sina and Xu, Peipei and Guang, Shanyi and Xu, Hongyao and Yin, Shouchun},
  title = {Spatiotemporally Engineered POSS Nanoplatform for Multi‐Organelle‐Targeted Synergistic Photothermal‐Chemo‐Immunotherapy},
  journal = {Advanced Healthcare Materials},
  year = {2026},
  volume = {15},
  number = {13},
  doi = {10.1002/adhm.202505008}
}
Kostenlos starten →